These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2190953)
41. The role of cytokines in rejection of discordant xenotransplants. Saadi S; Takahashi T; Nagayasu T; Holzknecht RA; Platt JL Transplant Proc; 1999; 31(1-2):911-2. PubMed ID: 10083400 [No Abstract] [Full Text] [Related]
42. Literature update 1999, part 3. Xenotransplantation. Auchincloss H Xenotransplantation; 2000 May; 7(2):156-62. PubMed ID: 10961300 [No Abstract] [Full Text] [Related]
43. Graft survival in a hamster-to-rat heart transplantation model after treatment with total lymphoid irradiation, cyclosporine A, and a monoclonal anti-T-cell antibody. Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C Transplant Proc; 1990 Jun; 22(3):1088. PubMed ID: 2349667 [No Abstract] [Full Text] [Related]
44. Multilineage bone marrow chimerism produces cellular and humoral tolerance in a mouse-to-rat cardiac xenograft. Mohiuddin MM; Qian X; Qin Y; DiSesa VJ Transplant Proc; 2000 Aug; 32(5):1029-30. PubMed ID: 10936334 [No Abstract] [Full Text] [Related]
45. Splenectomy is a potent immunosuppressive modality for cardiac xenografting. Carobbi A; Araneda D; Thomas F; Quarantillo P; Thomas J Transplant Proc; 1993 Feb; 25(1 Pt 1):419-20. PubMed ID: 8438360 [No Abstract] [Full Text] [Related]
46. Xenotransplantation: current status and a perspective on the future. Yang YG; Sykes M Nat Rev Immunol; 2007 Jul; 7(7):519-31. PubMed ID: 17571072 [TBL] [Abstract][Full Text] [Related]
48. The role of indirect recognition and TH2 response in cardiac xenograft rejection. Singh NP; Shirwan H Transplant Proc; 2001; 33(1-2):746. PubMed ID: 11267050 [No Abstract] [Full Text] [Related]
49. T-cell-directed immunosuppression allows prolonged survival of xenogeneic pig islets in monkeys. Jonker M; Rijkelijkhuizen JK; Haanstra KG; Kuhn EM; Ringers J; Bouwman E Transplant Proc; 2001; 33(1-2):726. PubMed ID: 11267041 [No Abstract] [Full Text] [Related]
50. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft. Elsen M; Soares M; Latinne D; Cornet A; Bazin H Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373 [No Abstract] [Full Text] [Related]
51. Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. Tsugita M; Valdivia LA; Celli S; Pan F; Sun H; Demetris AJ; Fung JJ; Starzl TE Transplant Proc; 1995 Feb; 27(1):277. PubMed ID: 7533393 [No Abstract] [Full Text] [Related]
52. Human cell-mediated rejection of porcine xenografts in an immunodeficient mouse model. Sawada T; DellaPelle PA; Seebach JD; Sachs DH; Colvin RB; Iacomini J Transplantation; 1997 May; 63(9):1331-8. PubMed ID: 9158029 [TBL] [Abstract][Full Text] [Related]
53. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation. Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417 [No Abstract] [Full Text] [Related]
54. [Elimination of natural antibodies in discordant xenografts]. Gianello P Pathol Biol (Paris); 1994 Mar; 42(3):225-9. PubMed ID: 8090571 [TBL] [Abstract][Full Text] [Related]
55. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031 [TBL] [Abstract][Full Text] [Related]
56. The future of transplantation biology and medicine. Medawar P Transplant Proc; 1969 Mar; 1(1):666-9. PubMed ID: 4944283 [No Abstract] [Full Text] [Related]